Immunologic consequences of chemotherapy for acute myeloid leukemia. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Immunologic consequences of chemotherapy for acute myeloid leukemia.

Reilly A, Kersun LS, Luning Prak E, Boyer J, McDonald K, Jawad AF, Sullivan KE. Immunologic consequences of chemotherapy for acute myeloid leukemia. J Pediatr Hematol Oncol. 2013 Jan; 35(1):46-53.

View in: PubMed

authors with profiles

Kathleen Sullivan, APRN, PMHCNS-BC

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support